Patent details
301112
Product Name:
COVID-19-vaccin (ChAdOx1-S [recombinant])
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301112
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2714916
Status:
Application Pending
Application number:
301112
Procedural language:
Dutch
First Applicant Residence Country:
United Kingdom (GB)
Marketing Authorization
1
Marketing Authorization Number:
EU/1/21/1529
Marketing Authorization Type:
EEA
Marketing Authorization Date:
29/01/2021
Marketing Authorization Country:
European Union (EU)
2
Marketing Authorization Number:
PLGB 17901/0355
Marketing Authorization Type:
EEA
Marketing Authorization Date:
29/12/2020
Marketing Authorization Country:
United Kingdom (GB)
Dates
Filing date:
25/06/2021
First Marketing Authorization date:
29/12/2020
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
28/06/2021
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
25/06/2021
Name:
Oxford University Innovation Limited
Address:
Buxton Court
3 West Way, Botley
Oxford OX2 0JB, United Kingdom (GB)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
25/06/2021
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
Bulletin Heading:
SPC
Journal edition number:
26/21
Publication date:
30/06/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
28/06/2021
Outgoing Correspondence
Confirmation receipt request
1
PDF
/3/3/4/7/9/0800697433/docs/301112_6_419683l174.pdf
25/06/2021
Application Form
First filed application form
2
PDF
/3/3/4/7/9/0800697433/docs/301112_0_applicationform20210628084021735.pdf
25/06/2021
SPC Documents
Annex SPC
11
PDF
/3/3/4/7/9/0800697433/docs/301112_1_supplprotectioncertificate20210628085940976.pdf
25/06/2021
SPC Documents
Summary of the characteristics of the product
11
PDF
/3/3/4/7/9/0800697433/docs/301112_2_supplprotectioncertificate20210628085106007.pdf
25/06/2021
SPC Documents
Annex SPC
57
PDF
/3/3/4/7/9/0800697433/docs/301112_3_supplprotectioncertificate20210628085941234.pdf
25/06/2021
SPC Documents
Marketing Authorization SPC
3
PDF
/3/3/4/7/9/0800697433/docs/301112_4_supplprotectioncertificate20210628084608761.pdf
25/06/2021
SPC Documents
Annex SPC
1
PDF
/3/3/4/7/9/0800697433/docs/301112_5_supplprotectioncertificate20210628084652748.pdf